Moderna CEO Talks New Drugs

Former New York Governor Andrew Cuomo is starting a second act: Helping cryptocurrency exchange operator OKX and the owner of the New York Stock Exchange build a new business that merges digital and traditional finance markets. Cuomo, who has advised OKX on policy matters includi ... Show More

Kaja Kallas, the European Union's foreign affairs chief, says the EU's role is to "strengthen" Ukraine. Speaking on Bloomberg Television from the 2026 NATO Summit in Ankara, Kallas adds that US troop movements in Europe do not affect the overall capability of defense and deterren ... Show More

Finland’s President Alexander Stubb says Europe and the US need to work on providing missiles for Ukraine, and that letting the nation make Patriots would be cost-effective. "We're seeing over 100 civilian buildings being hit just the other night with civilians dying," Stubb tell ... Show More

Dr. Vino Palli, CEO of MiDoctor Urgent Care, discusses the Covid virus and vaccinations. Businessweek Technology Editor Joshua Brustein talks about his Businessweek Magazine story Afghanistan War Turns a U.S. Military Startup Into a Unicorn. Bloomberg News Financial Regulations R ... Show More

Dr. Renee Dua, Chief Medical Officer of Heal, provides a coronavirus and vaccine update. Bloomberg Businessweek Editor Joel Weber and Bloomberg News Real Estate Reporter Patrick Clark talk about the story “Airbnb Salvaged Its IPO by Mastering the Pandemic Pivot.” Bloomberg News E ... Show More

On this edition of Bloomberg Businessweek, hosts Paul Sweeney and Matt Miller speak with Daniel Barel, CEO of REE Automotive, Chris Heller, co-founder of Cordillera Investment Partners, Nicola Hancock, Managing Director of the Americas at AMS, Vinh Vuong, CEO at Garrison Fathom a ... Show More

Bloomberg News Technology Reporter Matt Day discusses Amazon’s incoming CEO and his influence on the technology industry. Bishop T.D. Jakes, Chairman of the T.D. Jakes Foundation, shares thoughts on “Conversations with America: Understanding the COVID-19 Vaccine.” Bloomberg Busin ... Show More

Michael Dowling, CEO at Northwell Health, discusses the U.S. government expected to recommend booster shots eight months after people get their second vaccine dose. Bloomberg Businessweek Editor Joel Weber and Bloomberg News Deals Reporter Scott Deveau talk about how the SPAC boo ... Show More

Dr. Seth Lederman, CEO of Tonix Pharmaceuticals, discusses U.S. regulators granting full approval of the Covid-19 vaccine made by Pfzier and BioNtech, a milestone expected to help bolster the immunization drive. Bloomberg Law Health Care Reporter Shira Stein shares her story Preg ... Show More

Dr. Ken Redcross, Founder of Redcross Concierge, discusses Covid vaccines and communities most at risk. Bloomberg CityLab Reporter Kriston Capps talks about the story “Trump Has One Last Chance to Meddle With Census Numbers.” John Fieldly, CEO at Celsius Holdings, talks about the ... Show More

Dr. Ian Lustbader, Clinical Professor of Medicine at NYU Langone discusses the usefulness of vaccines. Greg Greifeld, Deputy Chief Investment Officer at Runway Growth Capital talks about venture debt. Sam Tabar, Chief Strategy Officer at Bit Digital, discusses the business of bit ... Show More

Vaccine-maker Moderna is also a data company, and that’s enabling it to use AI to drastically reduce drug-development times, Chief Information Officer Brad Miller tells Bloomberg Intelligence’s Sam Fazeli and Mandeep Singh. This episode of the Tech Disruptors podcast looks at a w ... Show More

Noubar Afeyan has started 76 companies over his career. One of those companies is Moderna, the COVID vaccine maker that recently surpassed Merck in market value. Afeyan discusses Moderna’s success and where his firm m, Flagship Pioneering, is looking for its next opportunity.See ... Show More